NO20082992L - Ostrogenmodulatorer - Google Patents
OstrogenmodulatorerInfo
- Publication number
- NO20082992L NO20082992L NO20082992A NO20082992A NO20082992L NO 20082992 L NO20082992 L NO 20082992L NO 20082992 A NO20082992 A NO 20082992A NO 20082992 A NO20082992 A NO 20082992A NO 20082992 L NO20082992 L NO 20082992L
- Authority
- NO
- Norway
- Prior art keywords
- ostrogenmodulatorer
- isoxazoles
- present application
- application relates
- new class
- Prior art date
Links
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 150000002545 isoxazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75278005P | 2005-12-22 | 2005-12-22 | |
| US80523306P | 2006-06-20 | 2006-06-20 | |
| PCT/IB2006/003671 WO2007072164A2 (fr) | 2005-12-22 | 2006-12-11 | Modulateurs d'oestrogenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082992L true NO20082992L (no) | 2008-09-22 |
Family
ID=38066616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082992A NO20082992L (no) | 2005-12-22 | 2008-07-02 | Ostrogenmodulatorer |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7470715B2 (fr) |
| EP (1) | EP1966170A2 (fr) |
| JP (1) | JP2009520808A (fr) |
| KR (1) | KR20080073346A (fr) |
| AP (1) | AP2008004481A0 (fr) |
| AR (1) | AR058611A1 (fr) |
| AU (1) | AU2006327877A1 (fr) |
| BR (1) | BRPI0620215A2 (fr) |
| CA (1) | CA2628596A1 (fr) |
| EA (1) | EA200801407A1 (fr) |
| EC (1) | ECSP088533A (fr) |
| NL (1) | NL2000351C2 (fr) |
| NO (1) | NO20082992L (fr) |
| PE (1) | PE20070815A1 (fr) |
| RS (1) | RS20080267A (fr) |
| UY (1) | UY30047A1 (fr) |
| WO (1) | WO2007072164A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013538800A (ja) * | 2010-08-10 | 2013-10-17 | アッヴィ・インコーポレイテッド | 新規ｔｒｐｖ３モジュレーター |
| CN111938907B (zh) * | 2020-08-12 | 2022-07-01 | 中国人民解放军陆军军医大学第一附属医院 | 一种鼻部手术后外敷面罩 |
| GB2608397B (en) * | 2021-06-29 | 2025-04-09 | Chaitowitz Ilan | Gynecomastia treatment |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US207927A (en) * | 1878-09-10 | Improvement in horse hay-rakes | ||
| US525666A (en) * | 1894-09-04 | Axel sarnmark | ||
| US171412A (en) * | 1875-12-21 | Improvement in buck-boards | ||
| US9799A (en) * | 1853-06-21 | Simon ikgeksoll | ||
| US256210A (en) * | 1882-04-11 | Bodolphe t | ||
| GB1012182A (en) | 1963-04-23 | 1965-12-08 | Ass Portland Cement | Improvement in the manufacture of hydraulic cement |
| JPS63108339A (ja) | 1986-10-27 | 1988-05-13 | Fuji Photo Film Co Ltd | ハロゲン化銀カラ−感光材料の処理方法 |
| GB2201672A (en) | 1986-12-18 | 1988-09-07 | Shell Int Research | Diphenyl ether compounds |
| US4952700A (en) | 1988-04-25 | 1990-08-28 | W.R. Grace & Co.-Conn. | Preparation of isoxazolines and isoxazoles |
| US4933464A (en) * | 1988-04-25 | 1990-06-12 | W. R. Grace & Co.-Conn. | Process for forming 3-phenylisoxazolines and 3-phenylisoxazoles |
| JPH089600B2 (ja) | 1988-08-02 | 1996-01-31 | 三井東圧化学株式会社 | ピラゾールカルボン酸類の製造方法 |
| JPH089599B2 (ja) | 1988-08-02 | 1996-01-31 | 三井東圧化学株式会社 | ピラゾールカルボン酸類の製造方法 |
| IT1228288B (it) | 1989-01-09 | 1991-06-07 | Zambon Spa | Composti ad attivita' antiserotoninica |
| DE4016049A1 (de) * | 1990-05-18 | 1991-11-21 | Basf Ag | 3-isoxazolylbenzylester, ihre herstellung und ihre verwendung |
| US5256632A (en) * | 1990-05-30 | 1993-10-26 | Bayer Aktiengesellschaft | Herbicidal sulphonylated carboxamides |
| DK178590D0 (da) | 1990-07-26 | 1990-07-26 | Novo Nordisk As | 1,4-disubstituerede piperaziner |
| US5260322A (en) | 1990-10-08 | 1993-11-09 | Merck & Co., Inc. | Angiotension II antagonists in the treatment of hyperuricemia |
| JP3010387B2 (ja) | 1991-05-13 | 2000-02-21 | コニカ株式会社 | ピラゾール誘導体 |
| JP3454531B2 (ja) * | 1991-11-07 | 2003-10-06 | 三共株式会社 | ニトロキシアルキルアミド誘導体 |
| DE4137940A1 (de) | 1991-11-18 | 1993-05-19 | Basf Ag | 3-isoxazolylphenylverbindungen, ihre herstellung und ihre verwendung |
| WO1994017059A1 (fr) | 1993-01-29 | 1994-08-04 | Nippon Soda Co., Ltd. | Derive heterocyclique |
| IT1263751B (it) | 1993-02-05 | 1996-08-27 | Mini Ricerca Scient Tecnolog | Derivati di esteri arilacetici ad attivita' fungicida |
| JPH06236057A (ja) | 1993-02-10 | 1994-08-23 | Fuji Xerox Co Ltd | 電子写真感光体 |
| JPH07304748A (ja) | 1993-06-29 | 1995-11-21 | Nissan Chem Ind Ltd | アルドキシム誘導体および農園芸用殺菌剤 |
| WO1995011896A1 (fr) | 1993-10-26 | 1995-05-04 | Nissan Chemical Industries, Ltd. | Derive de pyrazole substitue, et fongicide agricole et horticole |
| JP3791015B2 (ja) | 1994-03-31 | 2006-06-28 | 日産化学工業株式会社 | スルホンアミド誘導体の製造方法 |
| JP3329061B2 (ja) | 1994-04-19 | 2002-09-30 | 三菱化学株式会社 | 電子写真用感光体 |
| JPH0873436A (ja) | 1994-07-06 | 1996-03-19 | Nissan Chem Ind Ltd | セミカルバゾン誘導体 |
| US5486534A (en) | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
| FR2725988B1 (fr) | 1994-10-24 | 1997-01-24 | Roussel Uclaf | Nouveaux derives de pyrazolones et pyrazoles acides, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
| CN1117080A (zh) | 1995-01-11 | 1996-02-21 | 刘波 | 苏云金芽胞杆菌培养基 |
| JP3267300B2 (ja) * | 1995-02-13 | 2002-03-18 | ジー．ディー．サール アンド カンパニー | 炎症の治療のための置換イソオキサゾール |
| WO1996033994A1 (fr) | 1995-04-28 | 1996-10-31 | Nippon Soda Co., Ltd. | Derives amino-substitues, leur procede de preparation et herbicide |
| ATE301457T1 (de) * | 1995-06-12 | 2005-08-15 | Searle & Co | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
| BR9611047A (pt) | 1995-10-17 | 2000-03-08 | Searle & Co | Processo de deteção de ciclo oxigenase-2 |
| AU1952597A (en) | 1996-02-13 | 1997-09-02 | G.D. Searle & Co. | Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| GEP20032998B (en) | 1996-04-12 | 2003-06-25 | Searle & Co | Substituted Benzenesulfonamide Derivatives as Prodrugs of Cox-2 Inhibitors |
| JP3399756B2 (ja) * | 1996-10-22 | 2003-04-21 | 三菱製紙株式会社 | 平版印刷版の処理方法 |
| EA003733B1 (ru) * | 1997-09-05 | 2003-08-28 | Басф Акциенгезельшафт | Способ получения (гетеро) ароматических гидроксиламинов |
| US5972986A (en) * | 1997-10-14 | 1999-10-26 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| CA2372912C (fr) | 1997-10-14 | 2008-12-02 | G.D. Searle & Co. | Application d'inhibiteurs de la cyclogenase-2 au traitement et a la prevention du processus neoplasique |
| JPH11124306A (ja) | 1997-10-22 | 1999-05-11 | Nissan Chem Ind Ltd | 殺虫・殺ダニ・殺菌剤組成物 |
| ATE315033T1 (de) * | 1998-08-07 | 2006-02-15 | Chiron Corp | Subtituierte isoxazole derivate als estrogen rezeptor modulatore |
| AU1199600A (en) | 1998-10-02 | 2000-04-26 | Board Of Trustees Of The University Of Illinois, The | Estrogen receptor ligands |
| JP2003521468A (ja) * | 1999-03-17 | 2003-07-15 | シグナル ファーマシューティカルズ， インコーポレイテッド | エストロゲンレセプタを変調させるための化合物及び方法 |
| AU3253800A (en) | 1999-05-14 | 2000-11-16 | Pfizer Products Inc. | Combination therapy for the treatment of migraine |
| US6413965B1 (en) | 1999-06-30 | 2002-07-02 | Pfizer Inc. | Compositions and treatment for diabetic complications |
| CO5190678A1 (es) | 1999-06-30 | 2002-08-29 | Pfizer Prod Inc | Terapia combinada para el tratamiento de la migrana |
| JP4645871B2 (ja) | 1999-09-24 | 2011-03-09 | 日本農薬株式会社 | イソキサゾリン誘導体及び除草剤並びにその使用方法 |
| KR100479137B1 (ko) | 1999-12-02 | 2005-03-31 | 노파르티스 아게 | 살충제 및 항기생충제로서의 아미노헤테로시클릴아미드 |
| WO2001081332A2 (fr) | 2000-04-25 | 2001-11-01 | Pharmacia Corporation | Composes de 2-fluorobenzenesulfonyle utilises pour le traitement d'inflammations |
| JP2001302662A (ja) | 2000-04-27 | 2001-10-31 | Nissan Chem Ind Ltd | アクリロニトリル化合物 |
| JP4119246B2 (ja) | 2000-11-27 | 2008-07-16 | メルク エンド カムパニー インコーポレーテッド | エストロゲンレセプター修飾物質 |
| US6693295B2 (en) * | 2000-12-25 | 2004-02-17 | Fuji Photo Film Co., Ltd. | Indole derivative, material for light-emitting device and light-emitting device using the same |
| US7276523B2 (en) | 2001-03-30 | 2007-10-02 | Smithkline Beecham Corporation | Aminopyridine derivatives as estrogen receptor modulators |
| US6673818B2 (en) | 2001-04-20 | 2004-01-06 | Pharmacia Corporation | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
| EP1270535A3 (fr) * | 2001-06-20 | 2004-02-18 | Clariant GmbH | Méthode de préparation de composés aromatiques substitués |
| US6960607B2 (en) | 2001-12-13 | 2005-11-01 | Wyeth | Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents |
| US6884814B2 (en) | 2001-12-13 | 2005-04-26 | Wyeth | Phenyl benzisoxazoles as estrogenic agents |
| GB0130339D0 (en) | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
| JP4399265B2 (ja) | 2001-12-21 | 2010-01-13 | ヴァーナリス（ケンブリッジ）リミテッド | ３，４−ジアリールピラゾール、および癌の治療におけるそれらの使用 |
| AU2002367426A1 (en) | 2001-12-28 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Neurotrophic factor production/secretion accelerator |
| US6803379B2 (en) * | 2002-06-04 | 2004-10-12 | Jose A. Fernandez-Pol | Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets |
| PT1606307E (pt) | 2002-07-03 | 2007-11-21 | Ortho Mcneil Pharm Inc | Derivados de estrieno[3,2-b]/[3,4-c]pirrole úteis como moduladores dos receptores de estrogénio |
| WO2004026887A2 (fr) | 2002-09-19 | 2004-04-01 | Merck & Co., Inc. | Modulateurs des recepteurs des oestrogenes |
| CA2512000C (fr) | 2002-12-26 | 2011-08-09 | Eisai Co., Ltd. | Modulateurs selectifs des recepteurs d'oestrogene |
| WO2004073610A2 (fr) | 2003-02-13 | 2004-09-02 | Merck & Co., Inc. | Modulateurs des recepteurs des oestrogenes |
| WO2004073612A2 (fr) | 2003-02-13 | 2004-09-02 | Merck & Co. Inc. | Modulateurs de recepteur d'oestrogenes |
| WO2005000775A2 (fr) | 2003-05-31 | 2005-01-06 | Janssen Pharmaceutica, N.V. | Derives de cyclohexyle utilises comme modulateurs selectifs des recepteurs des oestrogenes |
| EP1692127B1 (fr) | 2003-10-08 | 2008-07-02 | Smithkline Beecham Corporation | Composes de triphenylethylene comme modulateurs selectifs du recepteur des oestrogenes |
| US20050256210A1 (en) | 2004-05-04 | 2005-11-17 | Roger Olsson | Compounds with activity at estrogen receptors |
-
2006
- 2006-12-04 NL NL2000351A patent/NL2000351C2/nl not_active IP Right Cessation
- 2006-12-11 AP AP2008004481A patent/AP2008004481A0/xx unknown
- 2006-12-11 RS RSP-2008/0267A patent/RS20080267A/sr unknown
- 2006-12-11 AU AU2006327877A patent/AU2006327877A1/en not_active Abandoned
- 2006-12-11 JP JP2008546673A patent/JP2009520808A/ja active Pending
- 2006-12-11 KR KR1020087015099A patent/KR20080073346A/ko not_active Ceased
- 2006-12-11 BR BRPI0620215-2A patent/BRPI0620215A2/pt not_active Application Discontinuation
- 2006-12-11 EA EA200801407A patent/EA200801407A1/xx unknown
- 2006-12-11 CA CA002628596A patent/CA2628596A1/fr not_active Abandoned
- 2006-12-11 EP EP06842247A patent/EP1966170A2/fr not_active Withdrawn
- 2006-12-11 WO PCT/IB2006/003671 patent/WO2007072164A2/fr not_active Ceased
- 2006-12-19 US US11/612,582 patent/US7470715B2/en not_active Expired - Fee Related
- 2006-12-20 UY UY30047A patent/UY30047A1/es not_active Application Discontinuation
- 2006-12-20 PE PE2006001664A patent/PE20070815A1/es not_active Application Discontinuation
- 2006-12-21 AR ARP060105717A patent/AR058611A1/es unknown
-
2008
- 2008-06-12 EC EC2008008533A patent/ECSP088533A/es unknown
- 2008-07-02 NO NO20082992A patent/NO20082992L/no not_active Application Discontinuation
- 2008-10-31 US US12/262,565 patent/US20090131397A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1966170A2 (fr) | 2008-09-10 |
| PE20070815A1 (es) | 2007-08-27 |
| US20070149564A1 (en) | 2007-06-28 |
| NL2000351C2 (nl) | 2007-09-11 |
| AP2008004481A0 (en) | 2008-06-30 |
| EA200801407A1 (ru) | 2008-10-30 |
| US20090131397A1 (en) | 2009-05-21 |
| NL2000351A1 (nl) | 2007-06-25 |
| RS20080267A (sr) | 2009-05-06 |
| AR058611A1 (es) | 2008-02-13 |
| AU2006327877A1 (en) | 2007-06-28 |
| WO2007072164A3 (fr) | 2007-10-04 |
| CA2628596A1 (fr) | 2007-06-28 |
| KR20080073346A (ko) | 2008-08-08 |
| WO2007072164A2 (fr) | 2007-06-28 |
| UY30047A1 (es) | 2007-07-31 |
| JP2009520808A (ja) | 2009-05-28 |
| BRPI0620215A2 (pt) | 2011-11-01 |
| ECSP088533A (es) | 2008-07-30 |
| US7470715B2 (en) | 2008-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20075693L (no) | Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme | |
| NO20055135D0 (no) | Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer | |
| DK1660491T3 (da) | Benzimidazol-, benzthiazol- og benzoxazolderivater og deres anvendelse som LTA4Hmodulatorer | |
| DK1789401T3 (da) | Isoxazolinderivater og deres anvendelse som herbicider | |
| CY1110491T1 (el) | Διαμορφωτες του υποδοχεα γλυκοκορτικοειδους αζαδεκαλινης | |
| EA200900781A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды | |
| NO20090994L (no) | 2-aminobenzoxazol karboxamider som 5HT3 modulatorer | |
| NO20076001L (no) | Tigecyklin og metoder for deres fremstilling | |
| CL2008000873A1 (es) | Compuestos derivados de pirrolidin amidas; composicion farmaceutica que comprende dichos compuestos; y su uso para tratar trombosis. | |
| ATE497853T1 (de) | Werkzeuganordnung | |
| CL2008002041A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad. | |
| BRPI0518752A2 (pt) | 1-alquinil-2-arilàxi-alquil-amidas e uso do mesmo como fungicidas | |
| DK1636228T3 (da) | Nye pyridopyraziner og deres anvendelse som kinasemodulatorer | |
| AR059444A1 (es) | Composiciones ramnolipidicas y metodos de uso relacionados | |
| DK2086932T3 (da) | Substituerede aryl-indol forbindelser og deres kynurenin/kynuramin-lignende metabolitter som terapeutiske midler | |
| DK1799649T3 (da) | 3-(2-hydroxyphenyl)-pyrazoler og deres anvendelse som hsp90-modulatorer | |
| CR11157A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica | |
| CL2009000665A1 (es) | Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas. | |
| EA200900780A1 (ru) | Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства | |
| NO20084290L (no) | Process to prepare sulfonyl chloride derivatives | |
| BRPI0606358A2 (pt) | uso de pelo menos um aminoditiol, processo e kit para a deformação permanente dos cabelos e aminotióis | |
| NO20064053L (no) | Androgen reseptormodulatorer | |
| NO20076026L (no) | Adrogenmodulatorer | |
| ECSP109874A (es) | Nuevos compuestos 892 | |
| DE502006005053D1 (de) | Spritzbare akustikmassen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |